The first indigenous made coronavirus vaccine named “Covaxin” will be launched on 15 August 2020 if human trials of the vaccine are successful. The vaccine is being developed by the Indian Council of Medical Research (ICMR) in partnership with Bharat Biotech International Limited.
A dozen institutes have been selected for clinical trials of the indigenous COVID-19 vaccine (BBV152 COVID vaccine), the government’s top medical research body, ICMR, has said. ICMR has asked the institutes to set up the clinical trials as a priority project.
“The vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune. ICMR and BBIL are jointly working for the pre-clinical as well as clinical development of this vaccine,” the ICMR said in a letter to the institutes.
“It is envisaged to launch the vaccine for public health use latest by 15th August 2020 after completion of all clinical trials,” the research body added.
The government in a letter has asked the institutes to corporate with each other and waste no time and provide the results as soon as possible.
“Non-compliance will be viewed very seriously. Therefore, you are advised to treat this project on highest priority and meet the given timelines without any lapse,” said ICMR’s letter.
The institutes selected for the clinical trial are in Visakhapatnam, Rohtak, New Delhi, Patna, Belgaum (Karnataka), Nagpur, Gorakhpur, Kattankulathur (Tamil Nadu), Hyderabad, Arya Nagar, Kanpur (Uttar Pradesh) and Goa.
As of now, institutes across the world are working on a dozen of corona vaccines but non has been approved yet.